Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients (Q73363962)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

main subject

hepatocellular carcinoma

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00086-8

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00086-8

31 December 2023

author name string

Ronnie Tung-Ping Poon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sheung-Tat Fan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12735128

31 December 2023

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S1055320702000868?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00086-8

https://api.elsevier.com/content/article/PII:S1055320702000868?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00086-8

Surgical oncology clinics of North America

31 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

35-50, viii

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of primary liver cancer

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Primary prevention of hepatocellular carcinoma in developing countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

The global burden of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Results of 280 liver resections for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Recurrence of hepatocellular carcinoma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Clinicopathologic and prognostic significance of the histologic activity of noncancerous liver tissue in hepatitis B virus-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomy for hepatocellular carcinoma. A further report

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900086-8

7 January 2021

Comparison of liver resection for hepatocellular carcinoma in hepatitis B and hepatitis C-related cirrhotic patients

12

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00086-8

Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy

31 December 2023

21

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00086-8

Aggressive management of recurrence following surgical resection of hepatocellular carcinoma

31 December 2023

23

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00086-8

Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma

31 December 2023

26

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00086-8

31 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735128%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference